Skip to content Skip to contact
Global Vox Populi

Medtech research company in Brazil

Medtech Innovation in Brazil: What Insights Drive Growth?

Brazil represents Latin America’s largest healthcare market, with significant investment and a growing demand for advanced medical technologies.

The country’s medtech sector is expanding, driven by both public and private health systems serving a population exceeding 215 million. This dynamic environment requires precise insights into adoption barriers, clinical needs, and regulatory pathways.

Global Vox Populi, a medtech research company in Brazil, provides the specialized medtech research capability needed to manage this complex Brazilian market effectively.

What we research in Brazil

We help medtech companies understand critical areas within Brazil. Our projects explore product adoption rates among healthcare professionals (HCPs) and hospital administrators.

We conduct market access studies, identifying key stakeholders and reimbursement challenges for new devices. Research often covers patient journeys, understanding their interaction with medical technology and treatment pathways.

We also assess brand health, concept test new devices, and map competitive environments across various therapeutic areas in Brazil. Each project scope is fully customized to the client’s specific objectives and research questions.

Why Medtech research fits (or struggles) in Brazil

Medtech research in Brazil effectively reaches specialized audiences like physicians, surgeons, hospital procurement teams, and health system managers through targeted recruitment.

Online surveys and qualitative research like in-depth interviews (IDIs) work well for busy professionals across major urban centers. However, reaching specific low-incidence specialists or those in remote Amazonian regions can present recruitment challenges due to infrastructure and geographic spread.

We address this by partnering with local medical associations and using professional databases. Language is exclusively Brazilian Portuguese, requiring native-speaking interviewers.

If a research question demands observing technology use in clinical settings, ethnographic studies or in-facility intercepts may be more suitable than pure survey methods, which we can also field.

How we run Medtech research in Brazil

Our recruitment for medtech research in Brazil primarily draws from verified in-country professional panels and specialized B2B databases of healthcare practitioners.

We also work with local fieldwork partners who have established relationships with medical societies and hospitals. Screening protocols are rigorous, confirming specialty, practice type, caseload, and relevant technology usage.

Quality checks include live validation calls and recent-participation flags to avoid professional respondents. Fieldwork formats range from online quantitative surveys (CAWI) to remote in-depth interviews (IDIs) conducted via secure platforms, and occasionally in-person interviews in major cities.

All research is conducted in Brazilian Portuguese. Our moderators and interviewers possess a strong understanding of medical terminology and clinical practice, often with backgrounds in healthcare or life sciences. They receive specific training on our research objectives and ethical guidelines.

During fieldwork, project managers conduct daily checks on data consistency and interview quality. Deliverables include detailed reports, raw data files, transcripts, and debrief decks, all formatted for clear strategic application.

Where we field in Brazil

Global Vox Populi conducts medtech research in Argentina and across Brazil’s key healthcare hubs and beyond.

Our fieldwork capabilities cover major metropolitan areas like São Paulo, Rio de Janeiro, Belo Horizonte, Porto Alegre, and Brasília, which concentrate significant healthcare infrastructure and specialist populations.

We also extend reach into regional centers across the South, Southeast, and Northeast, working with local partners to access a broader range of practitioners and patient segments.

For specific projects requiring insights from more remote areas, we employ tailored recruitment strategies, including community networks and digital outreach where feasible. All interactions and materials are managed in Brazilian Portuguese, delivering cultural and linguistic accuracy throughout the research process.

Methodology, standards, and ethics

We adhere strictly to global and local market research standards for all our projects in Brazil.

This includes the ESOMAR guidelines, the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision), and ISO 20252:2019 where applicable.

In Brazil, we align with the ethical frameworks set by ABEP (Associação Brasileira de Empresas de Pesquisa), the national research association.

Our methodology frameworks for medtech research draw on established principles: semi-structured guides and probing for IDIs, delivering deep exploration of physician attitudes and patient experiences; and rigorous sampling and weighting protocols for quantitative studies to represent target populations accurately.

Applying these standards to medtech research involves specific considerations. We obtain explicit informed consent from all participants, clearly detailing the research purpose, data usage, and anonymity guarantees. For healthcare professionals, this includes confirming no undue influence or conflict of interest.

Patient data is handled with the utmost sensitivity, always anonymized or pseudonymized according to LGPD requirements and project scope. We fully disclose the market research nature of the interaction and avoid any perception of medical advice or product promotion.

Quality assurance is integral to our Brazilian medtech projects. This involves peer review of research instruments, back-checks on a percentage of completed interviews for verification, and quota validation to maintain sample representation.

For quantitative data, we employ statistical validation techniques to identify outliers or inconsistencies. All qualitative transcripts undergo meticulous coding and thematic analysis, maintaining accurate interpretation of complex medical insights.

Drivers and barriers for Medtech research in Brazil

DRIVERS:

  • Brazil’s growing aging population and rising prevalence of chronic diseases drive demand for advanced medical technologies.
  • Increased private healthcare investment and expanding health insurance coverage also create opportunities for new device adoption.
  • The country’s strong academic and research institutions foster a receptive environment for innovation.
  • Also, the increasing digitalization of healthcare, accelerated by recent global events, encourages the use of digital health solutions and remote monitoring devices.

BARRIERS:

  • The complex and sometimes slow regulatory approval process by ANVISA (Agência Nacional de Vigilância Sanitária) can delay market entry for new medtech products.
  • Economic instability and currency fluctuations impact healthcare budgets and the affordability of imported technologies.
  • Significant regional disparities in healthcare infrastructure and access make nationwide research challenging.
  • Cultural sensitivities regarding specific health conditions or treatment choices require careful approach design.
  • Lastly, achieving high response rates from time-constrained, senior healthcare professionals remains a consistent recruitment hurdle.

Compliance and data handling under Brazil’s framework

All medtech research conducted in Brazil by Global Vox Populi fully complies with the Lei Geral de Proteção de Dados (LGPD), Law 13.709/2018. This framework governs the collection, processing, and storage of personal data.

For medtech projects, this means rigorous consent capture for any identifiable healthcare professional or patient data, with clear explanations of data use and retention policies.

Data residency requirements are observed, with data stored and processed within compliant jurisdictions or with appropriate transfer mechanisms. We prioritize anonymization and pseudonymization techniques, especially for sensitive health information, to protect individual privacy.

Participants retain full rights to access, correct, or withdraw their data, which we allow transparently according to LGPD provisions.

Top 20 industries we serve in Brazil

  • Medical Devices: User experience research, concept testing for new surgical instruments, market entry studies for diagnostic equipment.
  • Pharmaceutical & Biotech: HCP segmentation, treatment pathway mapping, market access for new drug delivery systems.
  • Healthcare Providers: Patient experience research in hospitals, physician satisfaction with medical equipment, operational efficiency studies.
  • Diagnostics: Adoption drivers for new lab tests, competitive intelligence for imaging technologies, point-of-care device evaluation.
  • Digital Health & Telemedicine: App usability testing, physician acceptance of remote monitoring, patient engagement with telehealth platforms.
  • Health Insurance: Policyholder satisfaction with health plans, brand perception of health insurance providers, service use patterns.
  • Government & Public Health: Public health campaign effectiveness, disease prevention program evaluation, perception of public healthcare services.
  • Veterinary Medicine: Pet owner attitudes towards animal medical devices, veterinarian perception of new treatments.
  • Biotechnology: Research on novel therapeutic areas, understanding market readiness for advanced therapies.
  • Dental Devices: Dentist preferences for new dental equipment, patient perceptions of dental procedures and technology.
  • Oncology: Oncologist treatment decisions, patient support program evaluation, market access for cancer therapies.
  • Cardiology: Cardiologist feedback on cardiac devices, patient experience with heart conditions and technology.
  • Orthopedics: Surgeon preferences for orthopedic implants, patient recovery processes after orthopedic surgery.
  • Neurology: Neurologist insights on neurostimulation devices, patient quality of life with neurological conditions.
  • Ophthalmology: Ophthalmologist adoption of new eye care technology, patient satisfaction with vision correction devices.
  • Surgical Robotics: Surgeon training needs, hospital investment drivers for robotic surgery systems.
  • Medical Imaging: Radiologist workflow optimization, patient comfort with imaging procedures.
  • Home Healthcare: Caregiver needs for home medical equipment, patient adherence to home therapy devices.
  • Rehabilitation: Physical therapist evaluation of assistive devices, patient outcomes with rehabilitation technologies.
  • Medical Software: EHR system usability, hospital IT decision-maker needs for clinical software.

Companies and brands in our research universe in Brazil

Research projects we field in Brazil regularly cover the competitive sets of category leaders such as Siemens Healthineers, Philips, and GE Healthcare, which are prominent across diagnostic imaging and medical equipment.

We also examine the market impact of companies like Johnson & Johnson Medical, Medtronic, and Stryker, leaders in surgical devices and implants.

Other key players whose categories shape our research scope in Brazil include Roche Diagnostics, Danaher, Abbott, and Becton Dickinson, important in laboratory diagnostics and consumables.

Local and regional healthcare providers like Hospital Albert Einstein, Sírio-Libanês, and Rede D’Or São Luiz often inform our understanding of service delivery and technology adoption.

Additionally, pharmaceutical giants with significant medical device portfolios, such as Pfizer and Novartis, feature in our competitive analysis.

Why teams choose Global Vox Populi for Medtech research in Brazil

Our Brazil desk runs on senior research directors with an average of 15+ years of experience in healthcare market research.

  1. We maintain a strong network of in-country fieldwork partners specializing in HCP and patient recruitment.
  2. Translation and back-translation of medical terminology are handled in-house by native Brazilian Portuguese speakers with life sciences backgrounds.
  3. Clients benefit from a single project lead from kickoff through debrief, delivering consistent communication and deep project understanding.
  4. We provide coded qualitative outputs while fieldwork is still in market, aiding faster decision-making for our medtech clients.
  5. You can share your brief with us anytime.

Frequently Asked Questions

Q: What kinds of clients commission Medtech research in Brazil?

A: We work with medical device manufacturers, pharmaceutical companies with device portfolios, digital health startups, and healthcare service providers. These clients seek insights on product development, market entry, competitive positioning, and patient or HCP experiences within the Brazilian healthcare system. Our projects support strategic decisions for both established and emerging players.

Q: How do you maintain sample quality for Brazil’s diverse population in medtech research?

A: We employ a multi-pronged approach, drawing from specialized professional panels, medical association databases, and in-country recruitment partners. Rigorous screening verifies professional credentials, clinical practice, and specific technology usage. For patient populations, we work with advocacy groups and clinics to maintain representative and ethically sourced samples across Brazil’s varied demographics and regions.

Q: Which languages do you cover in Brazil for medtech research?

A: All our medtech research in Brazil is conducted exclusively in Brazilian Portuguese. Our project managers, moderators, and interviewers are native speakers, achieving full comprehension of local nuances and medical terminology. We also provide professional translation and back-translation services for all research materials and deliverables to maintain accuracy.

Q: How do you reach hard-to-find audiences (HCPs, rare disease patients) in Brazil?

A: Reaching specialized HCPs or rare disease patients in Brazil requires targeted strategies. We use our network of local fieldwork partners, who have established relationships with key opinion leaders and specialist medical societies. We also work with patient advocacy groups and use advanced digital targeting for low-incidence segments, verifying ethical and compliant access to these critical populations.

Q: What is your approach to data privacy compliance under Brazil’s framework (LGPD)?

A: Our approach to data privacy in Brazil is fully compliant with LGPD. We implement strict protocols for informed consent, data minimization, and secure storage. All personal data, especially sensitive health information, is anonymized or pseudonymized whenever possible. We allow participants to exercise their data rights, including access and deletion requests, in line with Brazilian law.

Q: Can you combine Medtech research with other methods (qual + quant) in Brazil?

A: Yes, we frequently design mixed-method studies for medtech clients in Brazil. This often involves combining qualitative in-depth interviews with HCPs to explore complex attitudes, followed by quantitative surveys to validate findings across a broader sample. This approach provides a holistic view, merging rich contextual understanding with statistically reliable data for strategic clarity.

Q: How do you manage cultural sensitivity in Medtech research in Brazil?

A: Cultural sensitivity is essential in Brazilian medtech research. Our native Portuguese-speaking teams are trained in local customs and communication styles. We carefully design research instruments to avoid culturally inappropriate questions or framing. For sensitive health topics, we employ indirect questioning techniques and maintain a respectful, empathetic interview environment. This minimizes bias and encourages open participation.

Q: Do you handle both B2B (HCP) and patient/consumer research in Brazil?

A: Yes, we conduct both B2B research targeting healthcare professionals (HCPs) and B2C research involving patients or general consumers in Brazil. Our specialized recruitment channels for HCPs include verified professional databases and medical networks. For patients and consumers, we work with panels and community groups, verifying we access the right segments for medtech adoption and experience studies.

Q: What deliverables do clients receive at the end of a Medtech research project in Brazil?

A: Clients typically receive a detailed final report with key findings, strategic recommendations, and actionable insights specific to the Brazilian medtech market. We also provide a comprehensive debrief presentation, raw data files (quantitative), and full transcripts or audio recordings (qualitative), providing complete transparency and utility of the research outputs. All deliverables are in English unless otherwise specified.

Q: How do you handle quality assurance and back-checks for Medtech data in Brazil?

A: Our quality assurance process for medtech data in Brazil includes multiple layers. We conduct audio checks of qualitative interviews, verify quantitative survey responses for consistency and logic, and perform back-checks on a percentage of completed interviews to confirm participation and data accuracy. Our project managers also review data against quotas and screening criteria throughout fieldwork, maintaining high data integrity.

When your next research brief involves Brazil, let’s talk through it. Request A Quote or View Case Studies from our work.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study